

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | retinal cone cell development (GO:0046549) | 5.66990212 |
| 2 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 5.66686842 |
| 3 | rhodopsin mediated signaling pathway (GO:0016056) | 5.48670368 |
| 4 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.44404680 |
| 5 | synaptic vesicle maturation (GO:0016188) | 5.00765942 |
| 6 | photoreceptor cell development (GO:0042461) | 4.99906676 |
| 7 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.98674643 |
| 8 | retinal rod cell development (GO:0046548) | 4.78784257 |
| 9 | layer formation in cerebral cortex (GO:0021819) | 4.70265783 |
| 10 | eye photoreceptor cell development (GO:0042462) | 4.68131330 |
| 11 | protein localization to synapse (GO:0035418) | 4.63724676 |
| 12 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.59537297 |
| 13 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.53458034 |
| 14 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.48488063 |
| 15 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 4.47152523 |
| 16 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.42005016 |
| 17 | photoreceptor cell maintenance (GO:0045494) | 4.36271854 |
| 18 | synaptic vesicle exocytosis (GO:0016079) | 4.33413547 |
| 19 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.28120669 |
| 20 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.24687974 |
| 21 | vocalization behavior (GO:0071625) | 4.21564606 |
| 22 | locomotory exploration behavior (GO:0035641) | 4.19249137 |
| 23 | NIK/NF-kappaB signaling (GO:0038061) | 4.18653755 |
| 24 | glutamate secretion (GO:0014047) | 4.07738254 |
| 25 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.99917184 |
| 26 | phototransduction (GO:0007602) | 3.85350772 |
| 27 | negative regulation of cell killing (GO:0031342) | 3.83594334 |
| 28 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.83594334 |
| 29 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.81366057 |
| 30 | regulation of clathrin-mediated endocytosis (GO:2000369) | 3.72742631 |
| 31 | detection of light stimulus (GO:0009583) | 3.72615204 |
| 32 | protein localization to endosome (GO:0036010) | 3.70260623 |
| 33 | regulation of synaptic vesicle transport (GO:1902803) | 3.70153296 |
| 34 | detection of light stimulus involved in visual perception (GO:0050908) | 3.66261248 |
| 35 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.66261248 |
| 36 | neuron cell-cell adhesion (GO:0007158) | 3.62340928 |
| 37 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.58323336 |
| 38 | neuron recognition (GO:0008038) | 3.56966974 |
| 39 | B cell receptor signaling pathway (GO:0050853) | 3.56094029 |
| 40 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.54438390 |
| 41 | axonal fasciculation (GO:0007413) | 3.50283200 |
| 42 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.47711467 |
| 43 | regulation of synapse structural plasticity (GO:0051823) | 3.47534624 |
| 44 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.46885760 |
| 45 | phototransduction, visible light (GO:0007603) | 3.44213328 |
| 46 | dendritic spine morphogenesis (GO:0060997) | 3.44116309 |
| 47 | modulation by symbiont of host defense response (GO:0052031) | 3.43606255 |
| 48 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.43606255 |
| 49 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.43606255 |
| 50 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.43606255 |
| 51 | modulation by symbiont of host immune response (GO:0052553) | 3.43606255 |
| 52 | positive regulation by symbiont of host defense response (GO:0052509) | 3.43606255 |
| 53 | detection of visible light (GO:0009584) | 3.42705289 |
| 54 | dendrite morphogenesis (GO:0048813) | 3.41495244 |
| 55 | exploration behavior (GO:0035640) | 3.41000149 |
| 56 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.34025334 |
| 57 | cellular potassium ion homeostasis (GO:0030007) | 3.31022601 |
| 58 | myeloid dendritic cell differentiation (GO:0043011) | 3.29601614 |
| 59 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.27519738 |
| 60 | germinal center formation (GO:0002467) | 3.25909775 |
| 61 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.24841094 |
| 62 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.23098571 |
| 63 | visual perception (GO:0007601) | 3.20915357 |
| 64 | innervation (GO:0060384) | 3.17302006 |
| 65 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.16990264 |
| 66 | sensory perception of light stimulus (GO:0050953) | 3.16804205 |
| 67 | photoreceptor cell differentiation (GO:0046530) | 3.16621738 |
| 68 | eye photoreceptor cell differentiation (GO:0001754) | 3.16621738 |
| 69 | positive regulation of guanylate cyclase activity (GO:0031284) | 3.14920874 |
| 70 | positive regulation of synapse maturation (GO:0090129) | 3.14001802 |
| 71 | cellular response to type I interferon (GO:0071357) | 3.13786124 |
| 72 | type I interferon signaling pathway (GO:0060337) | 3.13786124 |
| 73 | neurotransmitter secretion (GO:0007269) | 3.12136801 |
| 74 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.12135364 |
| 75 | response to type I interferon (GO:0034340) | 3.10798164 |
| 76 | macrophage activation involved in immune response (GO:0002281) | 3.08684155 |
| 77 | response to peptidoglycan (GO:0032494) | 3.08179957 |
| 78 | cell migration in hindbrain (GO:0021535) | 3.07874668 |
| 79 | sodium ion export (GO:0071436) | 3.06199249 |
| 80 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.05449203 |
| 81 | dopamine receptor signaling pathway (GO:0007212) | 3.05001241 |
| 82 | barbed-end actin filament capping (GO:0051016) | 3.04700863 |
| 83 | regulation of antigen processing and presentation (GO:0002577) | 3.04248518 |
| 84 | activation of protein kinase A activity (GO:0034199) | 3.04099865 |
| 85 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.02788264 |
| 86 | immunoglobulin mediated immune response (GO:0016064) | 3.01060499 |
| 87 | modulation by symbiont of host cellular process (GO:0044068) | 3.00998972 |
| 88 | synaptic vesicle endocytosis (GO:0048488) | 3.00356058 |
| 89 | membrane hyperpolarization (GO:0060081) | 2.99874842 |
| 90 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.99638790 |
| 91 | positive regulation of neurotransmitter transport (GO:0051590) | 2.98536840 |
| 92 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.97866275 |
| 93 | response to pheromone (GO:0019236) | 2.97112886 |
| 94 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.95233157 |
| 95 | detection of other organism (GO:0098543) | 2.94168884 |
| 96 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.93981997 |
| 97 | B cell homeostasis (GO:0001782) | 2.93698213 |
| 98 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.93160917 |
| 99 | regulation of neurotransmitter secretion (GO:0046928) | 2.91116873 |
| 100 | regulation of postsynaptic membrane potential (GO:0060078) | 2.88553661 |
| 101 | regulation of early endosome to late endosome transport (GO:2000641) | 2.88322734 |
| 102 | positive regulation of membrane potential (GO:0045838) | 2.87992886 |
| 103 | axon extension (GO:0048675) | 2.87894670 |
| 104 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.86618554 |
| 105 | detection of bacterium (GO:0016045) | 2.86265464 |
| 106 | myeloid dendritic cell activation (GO:0001773) | 2.85580876 |
| 107 | clathrin coat assembly (GO:0048268) | 2.85382326 |
| 108 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.84871312 |
| 109 | nucleobase catabolic process (GO:0046113) | 2.83068666 |
| 110 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.82862862 |
| 111 | glutamate receptor signaling pathway (GO:0007215) | 2.82451199 |
| 112 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.82376218 |
| 113 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.82357243 |
| 114 | synaptic transmission, glutamatergic (GO:0035249) | 2.82305276 |
| 115 | postsynaptic membrane organization (GO:0001941) | 2.82130119 |
| 116 | regulation of vesicle fusion (GO:0031338) | 2.81944783 |
| 117 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.81310708 |
| 118 | B cell proliferation (GO:0042100) | 2.81022856 |
| 119 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.80061356 |
| 120 | response to muramyl dipeptide (GO:0032495) | 2.78965279 |
| 121 | protein-chromophore linkage (GO:0018298) | 2.78475493 |
| 122 | regulation of superoxide anion generation (GO:0032928) | 2.75874712 |
| 123 | T cell costimulation (GO:0031295) | 2.74935296 |
| 124 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.74535086 |
| 125 | T-helper 1 type immune response (GO:0042088) | 2.74343566 |
| 126 | stress fiber assembly (GO:0043149) | 2.74023147 |
| 127 | response to auditory stimulus (GO:0010996) | 2.73137670 |
| 128 | proline transport (GO:0015824) | 2.72567517 |
| 129 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.71687745 |
| 130 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.71000347 |
| 131 | establishment of nucleus localization (GO:0040023) | 2.70406376 |
| 132 | detection of external stimulus (GO:0009581) | 2.70152265 |
| 133 | lymphocyte costimulation (GO:0031294) | 2.69201793 |
| 134 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.67886006 |
| 135 | neuron-neuron synaptic transmission (GO:0007270) | 2.67721389 |
| 136 | regulation of defense response to virus by virus (GO:0050690) | 2.66704074 |
| 137 | pinocytosis (GO:0006907) | 2.65863956 |
| 138 | retina development in camera-type eye (GO:0060041) | 2.65626319 |
| 139 | Golgi transport vesicle coating (GO:0048200) | 2.65438626 |
| 140 | COPI coating of Golgi vesicle (GO:0048205) | 2.65438626 |
| 141 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.65193117 |
| 142 | regulation of guanylate cyclase activity (GO:0031282) | 2.65188151 |
| 143 | response to histamine (GO:0034776) | 2.65108199 |
| 144 | vesicle transport along microtubule (GO:0047496) | 2.64970509 |
| 145 | synapse assembly (GO:0007416) | 2.64660947 |
| 146 | negative regulation of interleukin-12 production (GO:0032695) | 2.64332103 |
| 147 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.64223577 |
| 148 | detection of abiotic stimulus (GO:0009582) | 2.63869826 |
| 149 | cell communication by electrical coupling (GO:0010644) | 2.63829885 |
| 150 | GMP metabolic process (GO:0046037) | 2.62740030 |
| 151 | organelle transport along microtubule (GO:0072384) | 2.62667559 |
| 152 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.62420442 |
| 153 | activation of MAPKKK activity (GO:0000185) | 2.60730731 |
| 154 | positive regulation of vesicle fusion (GO:0031340) | 2.57459731 |
| 155 | T cell migration (GO:0072678) | 2.57009815 |
| 156 | behavioral fear response (GO:0001662) | 2.56399593 |
| 157 | behavioral defense response (GO:0002209) | 2.56399593 |
| 158 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.55137590 |
| 159 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.54904448 |
| 160 | negative regulation of microtubule polymerization (GO:0031115) | 2.54720586 |
| 161 | long-term synaptic potentiation (GO:0060291) | 2.54486549 |
| 162 | neuron projection extension (GO:1990138) | 2.54144284 |
| 163 | dendritic cell differentiation (GO:0097028) | 2.53265875 |
| 164 | positive regulation of Rap GTPase activity (GO:0032854) | 2.53071314 |
| 165 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.51345179 |
| 166 | defense response to protozoan (GO:0042832) | 2.50634552 |
| 167 | activation of Rac GTPase activity (GO:0032863) | 2.48635473 |
| 168 | cell adhesion mediated by integrin (GO:0033627) | 2.48580751 |
| 169 | positive regulation of type 2 immune response (GO:0002830) | 2.48197186 |
| 170 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.46785110 |
| 171 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.46280172 |
| 172 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.45324669 |
| 173 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 2.45125844 |
| 174 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 2.45055168 |
| 175 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 2.45055168 |
| 176 | Fc-gamma receptor signaling pathway (GO:0038094) | 2.45055168 |
| 177 | regulation of extracellular matrix disassembly (GO:0010715) | 2.44351995 |
| 178 | response to laminar fluid shear stress (GO:0034616) | 2.44343066 |
| 179 | cellular response to interferon-gamma (GO:0071346) | 2.43200487 |
| 180 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.41641270 |
| 181 | detection of external biotic stimulus (GO:0098581) | 2.41384088 |
| 182 | thymic T cell selection (GO:0045061) | 2.40083147 |
| 183 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.39377713 |
| 184 | positive regulation of antigen processing and presentation (GO:0002579) | 2.37495323 |
| 185 | regulation of anoikis (GO:2000209) | 2.36483773 |
| 186 | regulation of protein heterodimerization activity (GO:0043497) | 2.35806585 |
| 187 | negative regulation of anoikis (GO:2000811) | 2.34836077 |
| 188 | signal complex assembly (GO:0007172) | 2.34562014 |
| 189 | positive regulation of interferon-alpha production (GO:0032727) | 2.34206934 |
| 190 | response to host (GO:0075136) | 2.32879391 |
| 191 | response to host defenses (GO:0052200) | 2.32879391 |
| 192 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.32879391 |
| 193 | positive thymic T cell selection (GO:0045059) | 2.32638028 |
| 194 | B cell mediated immunity (GO:0019724) | 2.32327900 |
| 195 | N-acetylneuraminate metabolic process (GO:0006054) | 2.31780946 |
| 196 | modulation by virus of host process (GO:0019054) | 2.31676737 |
| 197 | mannose metabolic process (GO:0006013) | 2.31169377 |
| 198 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.30990715 |
| 199 | negative regulation of bone resorption (GO:0045779) | 2.29248492 |
| 200 | glycosphingolipid catabolic process (GO:0046479) | 2.28240534 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.83148109 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.76711785 |
| 3 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.58677844 |
| 4 | * MYC_22102868_ChIP-Seq_BL_Human | 3.40601056 |
| 5 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.20722940 |
| 6 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.18741623 |
| 7 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.98192376 |
| 8 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.79936923 |
| 9 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.79649339 |
| 10 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.76566691 |
| 11 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.70288231 |
| 12 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.57915654 |
| 13 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.56217469 |
| 14 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.56217469 |
| 15 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.47841423 |
| 16 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.44845996 |
| 17 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.43768649 |
| 18 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.43387602 |
| 19 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.42407725 |
| 20 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.40868821 |
| 21 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.39294045 |
| 22 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.34461758 |
| 23 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.33912465 |
| 24 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.32755818 |
| 25 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.29398766 |
| 26 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.29308017 |
| 27 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.28564746 |
| 28 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.27224074 |
| 29 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.26377527 |
| 30 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.25824778 |
| 31 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.22343137 |
| 32 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.18597258 |
| 33 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.18062640 |
| 34 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.14675075 |
| 35 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.14343230 |
| 36 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.13545211 |
| 37 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.12717864 |
| 38 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.11378512 |
| 39 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.09014133 |
| 40 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.07190905 |
| 41 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.05365630 |
| 42 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.99311056 |
| 43 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.95618442 |
| 44 | MAF_26560356_Chip-Seq_TH1_Human | 1.94521535 |
| 45 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.87213770 |
| 46 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.85096125 |
| 47 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.85031305 |
| 48 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.81850973 |
| 49 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.80953854 |
| 50 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.80525576 |
| 51 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.79971201 |
| 52 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.79891630 |
| 53 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.78388710 |
| 54 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.77917219 |
| 55 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.76387267 |
| 56 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.75828798 |
| 57 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.75741239 |
| 58 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.71979601 |
| 59 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.68081487 |
| 60 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.66143910 |
| 61 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.64680715 |
| 62 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.64491558 |
| 63 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.62036470 |
| 64 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.61388005 |
| 65 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.60578557 |
| 66 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.60362660 |
| 67 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.60342977 |
| 68 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.57933985 |
| 69 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.57852718 |
| 70 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.57791360 |
| 71 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.57729601 |
| 72 | KDM2B_26808549_Chip-Seq_K562_Human | 1.56078536 |
| 73 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.51945428 |
| 74 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.51852279 |
| 75 | SPI1_23127762_ChIP-Seq_K562_Human | 1.49887870 |
| 76 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.49378179 |
| 77 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49291676 |
| 78 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.48457183 |
| 79 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.47957635 |
| 80 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.47930497 |
| 81 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.45513323 |
| 82 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.44506136 |
| 83 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.44350232 |
| 84 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.44130579 |
| 85 | UTX_26944678_Chip-Seq_JUKART_Human | 1.42936363 |
| 86 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.41884998 |
| 87 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.41116558 |
| 88 | MAF_26560356_Chip-Seq_TH2_Human | 1.40168093 |
| 89 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.39851054 |
| 90 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.39802683 |
| 91 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.39528860 |
| 92 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.39233354 |
| 93 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.39141678 |
| 94 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.38327685 |
| 95 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.38192570 |
| 96 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.36386383 |
| 97 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.35366298 |
| 98 | MYB_26560356_Chip-Seq_TH1_Human | 1.34899089 |
| 99 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.34256494 |
| 100 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.33548784 |
| 101 | MYB_26560356_Chip-Seq_TH2_Human | 1.31681707 |
| 102 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.31057365 |
| 103 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.30602821 |
| 104 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.29870445 |
| 105 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.28763498 |
| 106 | AR_19668381_ChIP-Seq_PC3_Human | 1.27378268 |
| 107 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.25012772 |
| 108 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.24528814 |
| 109 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.23489957 |
| 110 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.22857384 |
| 111 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.21669420 |
| 112 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.21288576 |
| 113 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.20894045 |
| 114 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.20872499 |
| 115 | P300_19829295_ChIP-Seq_ESCs_Human | 1.20452161 |
| 116 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.19811538 |
| 117 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.19786131 |
| 118 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.19602352 |
| 119 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.19347381 |
| 120 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.18393571 |
| 121 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.18220420 |
| 122 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.17854899 |
| 123 | * P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.17003791 |
| 124 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.16232328 |
| 125 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.15075286 |
| 126 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.14307985 |
| 127 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.13933671 |
| 128 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.12724624 |
| 129 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.12026112 |
| 130 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11547888 |
| 131 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.11317684 |
| 132 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.10832069 |
| 133 | AR_25329375_ChIP-Seq_VCAP_Human | 1.10761135 |
| 134 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.10604873 |
| 135 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.10604873 |
| 136 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.10241229 |
| 137 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.10105818 |
| 138 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.09607249 |
| 139 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.08859082 |
| 140 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.08665611 |
| 141 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.08197492 |
| 142 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.08174084 |
| 143 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.06899509 |
| 144 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.05376246 |
| 145 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.05355425 |
| 146 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.05265446 |
| 147 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.05084893 |
| 148 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04437825 |
| 149 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.03707501 |
| 150 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.03525202 |
| 151 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.02821530 |
| 152 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.02811845 |
| 153 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.02455795 |
| 154 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.02019467 |
| 155 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.01743054 |
| 156 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.01577089 |
| 157 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.01384111 |
| 158 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.01355875 |
| 159 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.01260723 |
| 160 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.01089099 |
| 161 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00699501 |
| 162 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.00543818 |
| 163 | STAT3_23295773_ChIP-Seq_U87_Human | 1.00127788 |
| 164 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.00127314 |
| 165 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.99560984 |
| 166 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.99517892 |
| 167 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.99442880 |
| 168 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.98847769 |
| 169 | ATF3_27146783_Chip-Seq_COLON_Human | 0.97878679 |
| 170 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.97691295 |
| 171 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.97333035 |
| 172 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.97240411 |
| 173 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.96836442 |
| 174 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.96566613 |
| 175 | * RNF2_27304074_Chip-Seq_NSC_Mouse | 0.96433864 |
| 176 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.96002434 |
| 177 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96002434 |
| 178 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.95394361 |
| 179 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.95165808 |
| 180 | * SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.93802234 |
| 181 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.93636586 |
| 182 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.93093318 |
| 183 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92503183 |
| 184 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.91956636 |
| 185 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.90983984 |
| 186 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.90574210 |
| 187 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.90195731 |
| 188 | TP53_16413492_ChIP-PET_HCT116_Human | 0.89991141 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005551_abnormal_eye_electrophysiolog | 5.09299625 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 4.84594131 |
| 3 | MP0003011_delayed_dark_adaptation | 4.00608229 |
| 4 | MP0006072_abnormal_retinal_apoptosis | 3.60432674 |
| 5 | MP0005253_abnormal_eye_physiology | 3.43482113 |
| 6 | MP0000685_abnormal_immune_system | 3.28570002 |
| 7 | MP0001835_abnormal_antigen_presentation | 3.17335995 |
| 8 | MP0003300_gastrointestinal_ulcer | 3.16251847 |
| 9 | MP0005423_abnormal_somatic_nervous | 3.08414305 |
| 10 | MP0003880_abnormal_central_pattern | 3.05168558 |
| 11 | MP0003635_abnormal_synaptic_transmissio | 3.02414289 |
| 12 | MP0003705_abnormal_hypodermis_morpholog | 2.91957932 |
| 13 | MP0004270_analgesia | 2.88823317 |
| 14 | MP0001790_abnormal_immune_system | 2.84510741 |
| 15 | MP0005387_immune_system_phenotype | 2.84510741 |
| 16 | MP0003436_decreased_susceptibility_to | 2.60930893 |
| 17 | MP0002063_abnormal_learning/memory/cond | 2.53263794 |
| 18 | MP0000569_abnormal_digit_pigmentation | 2.41664165 |
| 19 | MP0003091_abnormal_cell_migration | 2.41617441 |
| 20 | MP0001800_abnormal_humoral_immune | 2.39852874 |
| 21 | MP0003763_abnormal_thymus_physiology | 2.36765848 |
| 22 | MP0005000_abnormal_immune_tolerance | 2.33751193 |
| 23 | MP0005195_abnormal_posterior_eye | 2.30482701 |
| 24 | MP0001968_abnormal_touch/_nociception | 2.26971183 |
| 25 | MP0005058_abnormal_lysosome_morphology | 2.25180361 |
| 26 | MP0005671_abnormal_response_to | 2.24105468 |
| 27 | MP0001984_abnormal_olfaction | 2.20150382 |
| 28 | MP0002734_abnormal_mechanical_nocicepti | 2.18243315 |
| 29 | MP0002452_abnormal_antigen_presenting | 2.15578231 |
| 30 | MP0010352_gastrointestinal_tract_polyps | 2.11391870 |
| 31 | MP0009745_abnormal_behavioral_response | 2.10373871 |
| 32 | MP0000778_abnormal_nervous_system | 2.09056433 |
| 33 | MP0005451_abnormal_body_composition | 2.08994559 |
| 34 | MP0002877_abnormal_melanocyte_morpholog | 1.99405980 |
| 35 | MP0002064_seizures | 1.98464360 |
| 36 | MP0008438_abnormal_cutaneous_collagen | 1.95601937 |
| 37 | MP0002723_abnormal_immune_serum | 1.95495963 |
| 38 | MP0003566_abnormal_cell_adhesion | 1.95260679 |
| 39 | MP0002184_abnormal_innervation | 1.94888365 |
| 40 | MP0002090_abnormal_vision | 1.92545555 |
| 41 | MP0002420_abnormal_adaptive_immunity | 1.91494900 |
| 42 | MP0001819_abnormal_immune_cell | 1.90174772 |
| 43 | MP0002148_abnormal_hypersensitivity_rea | 1.89706050 |
| 44 | MP0004947_skin_inflammation | 1.88621390 |
| 45 | MP0003191_abnormal_cellular_cholesterol | 1.86266877 |
| 46 | MP0005025_abnormal_response_to | 1.85739306 |
| 47 | MP0003172_abnormal_lysosome_physiology | 1.85500672 |
| 48 | MP0002419_abnormal_innate_immunity | 1.84072387 |
| 49 | MP0002572_abnormal_emotion/affect_behav | 1.83914271 |
| 50 | MP0009780_abnormal_chondrocyte_physiolo | 1.80380840 |
| 51 | MP0002882_abnormal_neuron_morphology | 1.78881083 |
| 52 | MP0009785_altered_susceptibility_to | 1.77916612 |
| 53 | MP0001502_abnormal_circadian_rhythm | 1.76433263 |
| 54 | MP0009840_abnormal_foam_cell | 1.75628430 |
| 55 | MP0009046_muscle_twitch | 1.74968586 |
| 56 | MP0001486_abnormal_startle_reflex | 1.74883096 |
| 57 | MP0010155_abnormal_intestine_physiology | 1.74626437 |
| 58 | MP0001324_abnormal_eye_pigmentation | 1.73394247 |
| 59 | MP0004858_abnormal_nervous_system | 1.72022767 |
| 60 | MP0008260_abnormal_autophagy | 1.71816161 |
| 61 | MP0002735_abnormal_chemical_nociception | 1.69772478 |
| 62 | MP0004811_abnormal_neuron_physiology | 1.66280091 |
| 63 | MP0005391_vision/eye_phenotype | 1.65266468 |
| 64 | MP0002229_neurodegeneration | 1.60543420 |
| 65 | MP0001853_heart_inflammation | 1.60442822 |
| 66 | MP0009333_abnormal_splenocyte_physiolog | 1.58516380 |
| 67 | MP0003724_increased_susceptibility_to | 1.56745578 |
| 68 | MP0003075_altered_response_to | 1.56552391 |
| 69 | MP0002653_abnormal_ependyma_morphology | 1.56208849 |
| 70 | MP0002736_abnormal_nociception_after | 1.55602490 |
| 71 | MP0002752_abnormal_somatic_nervous | 1.55141840 |
| 72 | MP0005499_abnormal_olfactory_system | 1.54734687 |
| 73 | MP0005394_taste/olfaction_phenotype | 1.54734687 |
| 74 | MP0002398_abnormal_bone_marrow | 1.52263973 |
| 75 | MP0003453_abnormal_keratinocyte_physiol | 1.50916185 |
| 76 | MP0000716_abnormal_immune_system | 1.50824270 |
| 77 | MP0010386_abnormal_urinary_bladder | 1.50166052 |
| 78 | MP0000858_altered_metastatic_potential | 1.49244379 |
| 79 | MP0002272_abnormal_nervous_system | 1.47872583 |
| 80 | MP0006082_CNS_inflammation | 1.46327248 |
| 81 | MP0003448_altered_tumor_morphology | 1.45968383 |
| 82 | MP0005464_abnormal_platelet_physiology | 1.45146556 |
| 83 | MP0002067_abnormal_sensory_capabilities | 1.43809400 |
| 84 | MP0002638_abnormal_pupillary_reflex | 1.43528667 |
| 85 | MP0002733_abnormal_thermal_nociception | 1.42827822 |
| 86 | MP0002557_abnormal_social/conspecific_i | 1.42305136 |
| 87 | MP0001533_abnormal_skeleton_physiology | 1.40716968 |
| 88 | MP0005257_abnormal_intraocular_pressure | 1.40045457 |
| 89 | MP0001970_abnormal_pain_threshold | 1.40020346 |
| 90 | MP0001845_abnormal_inflammatory_respons | 1.38236260 |
| 91 | MP0005187_abnormal_penis_morphology | 1.36794474 |
| 92 | MP0002405_respiratory_system_inflammati | 1.35410253 |
| 93 | MP0002998_abnormal_bone_remodeling | 1.34209908 |
| 94 | MP0008789_abnormal_olfactory_epithelium | 1.33110899 |
| 95 | MP0001849_ear_inflammation | 1.32214017 |
| 96 | MP0000604_amyloidosis | 1.30766639 |
| 97 | MP0003279_aneurysm | 1.28416865 |
| 98 | MP0001440_abnormal_grooming_behavior | 1.26573503 |
| 99 | MP0002909_abnormal_adrenal_gland | 1.25417256 |
| 100 | MP0002429_abnormal_blood_cell | 1.23474240 |
| 101 | MP0008569_lethality_at_weaning | 1.23304351 |
| 102 | MP0004885_abnormal_endolymph | 1.23043976 |
| 103 | MP0006276_abnormal_autonomic_nervous | 1.22948607 |
| 104 | MP0004924_abnormal_behavior | 1.21873477 |
| 105 | MP0005386_behavior/neurological_phenoty | 1.21873477 |
| 106 | MP0000343_altered_response_to | 1.21268224 |
| 107 | MP0005023_abnormal_wound_healing | 1.19810230 |
| 108 | MP0001958_emphysema | 1.18524629 |
| 109 | MP0000465_gastrointestinal_hemorrhage | 1.18507038 |
| 110 | MP0000955_abnormal_spinal_cord | 1.15141374 |
| 111 | MP0005623_abnormal_meninges_morphology | 1.15022692 |
| 112 | MP0002722_abnormal_immune_system | 1.14910367 |
| 113 | MP0000689_abnormal_spleen_morphology | 1.14902772 |
| 114 | MP0001501_abnormal_sleep_pattern | 1.10688261 |
| 115 | MP0002152_abnormal_brain_morphology | 1.08598063 |
| 116 | MP0004808_abnormal_hematopoietic_stem | 1.08346015 |
| 117 | MP0001348_abnormal_lacrimal_gland | 1.08176616 |
| 118 | MP0003690_abnormal_glial_cell | 1.07304568 |
| 119 | MP0005166_decreased_susceptibility_to | 1.07060724 |
| 120 | MP0002138_abnormal_hepatobiliary_system | 1.05974092 |
| 121 | MP0001299_abnormal_eye_distance/ | 1.03714081 |
| 122 | MP0003787_abnormal_imprinting | 1.03010316 |
| 123 | MP0005248_abnormal_Harderian_gland | 1.02663890 |
| 124 | MP0010234_abnormal_vibrissa_follicle | 1.01796794 |
| 125 | MP0002166_altered_tumor_susceptibility | 1.01681339 |
| 126 | MP0003122_maternal_imprinting | 1.01675739 |
| 127 | MP0003329_amyloid_beta_deposits | 1.00958463 |
| 128 | MP0000703_abnormal_thymus_morphology | 0.99084536 |
| 129 | MP0000490_abnormal_crypts_of | 0.98942341 |
| 130 | MP0005645_abnormal_hypothalamus_physiol | 0.98565252 |
| 131 | MP0003879_abnormal_hair_cell | 0.98414490 |
| 132 | MP0004233_abnormal_muscle_weight | 0.97485883 |
| 133 | MP0002066_abnormal_motor_capabilities/c | 0.95796905 |
| 134 | MP0005621_abnormal_cell_physiology | 0.95642263 |
| 135 | MP0000631_abnormal_neuroendocrine_gland | 0.93687632 |
| 136 | MP0004510_myositis | 0.93159230 |
| 137 | MP0008469_abnormal_protein_level | 0.93136723 |
| 138 | MP0003634_abnormal_glial_cell | 0.92950272 |
| 139 | MP0003866_abnormal_defecation | 0.92196520 |
| 140 | MP0001873_stomach_inflammation | 0.91549534 |
| 141 | MP0003045_fibrosis | 0.89558310 |
| 142 | MP0008874_decreased_physiological_sensi | 0.88964828 |
| 143 | MP0002234_abnormal_pharynx_morphology | 0.87352133 |
| 144 | MP0000249_abnormal_blood_vessel | 0.86990894 |
| 145 | MP0004742_abnormal_vestibular_system | 0.85533588 |
| 146 | MP0000767_abnormal_smooth_muscle | 0.83160084 |
| 147 | MP0003861_abnormal_nervous_system | 0.81238779 |
| 148 | MP0009764_decreased_sensitivity_to | 0.80197687 |
| 149 | MP0002060_abnormal_skin_morphology | 0.80017286 |
| 150 | MP0000537_abnormal_urethra_morphology | 0.79877637 |
| 151 | MP0003795_abnormal_bone_structure | 0.79552249 |
| 152 | MP0004883_abnormal_blood_vessel | 0.78226850 |
| 153 | MP0003633_abnormal_nervous_system | 0.74592756 |
| 154 | MP0003828_pulmonary_edema | 0.74570408 |
| 155 | MP0009278_abnormal_bone_marrow | 0.73634340 |
| 156 | MP0002163_abnormal_gland_morphology | 0.72571845 |
| 157 | MP0008961_abnormal_basal_metabolism | 0.71937996 |
| 158 | MP0002254_reproductive_system_inflammat | 0.71309912 |
| 159 | MP0005165_increased_susceptibility_to | 0.70929228 |
| 160 | MP0002006_tumorigenesis | 0.70751545 |
| 161 | MP0005197_abnormal_uvea_morphology | 0.70463325 |
| 162 | MP0005076_abnormal_cell_differentiation | 0.69631238 |
| 163 | MP0000920_abnormal_myelination | 0.68959079 |
| 164 | MP0001663_abnormal_digestive_system | 0.68948827 |
| 165 | MP0003183_abnormal_peptide_metabolism | 0.68635449 |
| 166 | MP0005390_skeleton_phenotype | 0.68437851 |
| 167 | MP0010307_abnormal_tumor_latency | 0.67924976 |
| 168 | MP0001346_abnormal_lacrimal_gland | 0.67612308 |
| 169 | MP0004085_abnormal_heartbeat | 0.67028558 |
| 170 | MP0001216_abnormal_epidermal_layer | 0.66731303 |
| 171 | MP0000534_abnormal_ureter_morphology | 0.65903027 |
| 172 | MP0004272_abnormal_basement_membrane | 0.65716936 |
| 173 | MP0003303_peritoneal_inflammation | 0.59839892 |
| 174 | MP0000751_myopathy | 0.59282971 |
| 175 | MP0003890_abnormal_embryonic-extraembry | 0.59003384 |
| 176 | MP0001963_abnormal_hearing_physiology | 0.58862665 |
| 177 | MP0002069_abnormal_eating/drinking_beha | 0.58427559 |
| 178 | MP0003631_nervous_system_phenotype | 0.57561808 |
| 179 | MP0002751_abnormal_autonomic_nervous | 0.57102680 |
| 180 | MP0003385_abnormal_body_wall | 0.56527743 |
| 181 | MP0010030_abnormal_orbit_morphology | 0.54233084 |
| 182 | MP0005646_abnormal_pituitary_gland | 0.53664934 |
| 183 | MP0001177_atelectasis | 0.51875670 |
| 184 | MP0001188_hyperpigmentation | 0.51664627 |
| 185 | MP0002081_perinatal_lethality | 0.50944812 |
| 186 | MP0001943_abnormal_respiration | 0.49912306 |
| 187 | MP0004215_abnormal_myocardial_fiber | 0.49751419 |
| 188 | MP0005310_abnormal_salivary_gland | 0.45310841 |
| 189 | MP0002089_abnormal_postnatal_growth/wei | 0.44842914 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Congenital stationary night blindness (HP:0007642) | 7.48912386 |
| 2 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 7.11540843 |
| 3 | Bony spicule pigmentary retinopathy (HP:0007737) | 6.61786975 |
| 4 | Abnormal rod and cone electroretinograms (HP:0008323) | 6.51829078 |
| 5 | Central scotoma (HP:0000603) | 6.19424665 |
| 6 | Abnormality of macular pigmentation (HP:0008002) | 5.71790091 |
| 7 | Chorioretinal atrophy (HP:0000533) | 5.70385261 |
| 8 | Pendular nystagmus (HP:0012043) | 5.44798925 |
| 9 | Abolished electroretinogram (ERG) (HP:0000550) | 5.23394232 |
| 10 | Pigmentary retinal degeneration (HP:0001146) | 5.21708700 |
| 11 | Dyschromatopsia (HP:0007641) | 5.20039746 |
| 12 | Scotoma (HP:0000575) | 5.12495496 |
| 13 | Posterior subcapsular cataract (HP:0007787) | 4.14925312 |
| 14 | Decreased central vision (HP:0007663) | 3.87677941 |
| 15 | Gastrointestinal stroma tumor (HP:0100723) | 3.87501795 |
| 16 | Severe visual impairment (HP:0001141) | 3.74972554 |
| 17 | Vitreoretinal degeneration (HP:0000655) | 3.73296433 |
| 18 | Type II diabetes mellitus (HP:0005978) | 3.70964708 |
| 19 | Photophobia (HP:0000613) | 3.46780194 |
| 20 | Increased corneal curvature (HP:0100692) | 3.45072276 |
| 21 | Keratoconus (HP:0000563) | 3.45072276 |
| 22 | Attenuation of retinal blood vessels (HP:0007843) | 3.42749661 |
| 23 | Cellulitis (HP:0100658) | 3.41192953 |
| 24 | Eczematoid dermatitis (HP:0000976) | 3.38337316 |
| 25 | Cone-rod dystrophy (HP:0000548) | 3.37051988 |
| 26 | Macular degeneration (HP:0000608) | 3.37021426 |
| 27 | Visual hallucinations (HP:0002367) | 3.20795722 |
| 28 | Focal motor seizures (HP:0011153) | 3.20384850 |
| 29 | Agammaglobulinemia (HP:0004432) | 3.16028225 |
| 30 | Constricted visual fields (HP:0001133) | 3.15802705 |
| 31 | Epileptic encephalopathy (HP:0200134) | 3.15142712 |
| 32 | Emphysema (HP:0002097) | 3.11313418 |
| 33 | Myokymia (HP:0002411) | 3.04992166 |
| 34 | Abnormality of glycolipid metabolism (HP:0010969) | 3.04222676 |
| 35 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.04222676 |
| 36 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.04222676 |
| 37 | Choroideremia (HP:0001139) | 3.03487169 |
| 38 | Focal seizures (HP:0007359) | 2.98293297 |
| 39 | Colitis (HP:0002583) | 2.97428131 |
| 40 | Abnormality of macrophages (HP:0004311) | 2.96506502 |
| 41 | Recurrent bacterial skin infections (HP:0005406) | 2.71757327 |
| 42 | Vertebral compression fractures (HP:0002953) | 2.71752065 |
| 43 | Febrile seizures (HP:0002373) | 2.67132131 |
| 44 | Mediastinal lymphadenopathy (HP:0100721) | 2.66107585 |
| 45 | Recurrent abscess formation (HP:0002722) | 2.65633585 |
| 46 | Premature rupture of membranes (HP:0001788) | 2.61710270 |
| 47 | Recurrent viral infections (HP:0004429) | 2.60804452 |
| 48 | Subcapsular cataract (HP:0000523) | 2.60434960 |
| 49 | Meningitis (HP:0001287) | 2.56668781 |
| 50 | Protrusio acetabuli (HP:0003179) | 2.55551910 |
| 51 | Vasculitis (HP:0002633) | 2.47410092 |
| 52 | Dysostosis multiplex (HP:0000943) | 2.44946124 |
| 53 | Mutism (HP:0002300) | 2.41203943 |
| 54 | Retinitis pigmentosa (HP:0000510) | 2.40944116 |
| 55 | Lymphopenia (HP:0001888) | 2.40219546 |
| 56 | Atrophic scars (HP:0001075) | 2.37751009 |
| 57 | Restrictive lung disease (HP:0002091) | 2.36492833 |
| 58 | Papilledema (HP:0001085) | 2.35336637 |
| 59 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.35006475 |
| 60 | Recurrent bronchitis (HP:0002837) | 2.33947238 |
| 61 | Gastrointestinal inflammation (HP:0004386) | 2.30592805 |
| 62 | Spontaneous hematomas (HP:0007420) | 2.30102429 |
| 63 | Osteomyelitis (HP:0002754) | 2.29111916 |
| 64 | Inflammation of the large intestine (HP:0002037) | 2.27669678 |
| 65 | Supranuclear gaze palsy (HP:0000605) | 2.26293708 |
| 66 | IgA deficiency (HP:0002720) | 2.25825865 |
| 67 | Progressive cerebellar ataxia (HP:0002073) | 2.25548189 |
| 68 | Increased connective tissue (HP:0009025) | 2.25267838 |
| 69 | Insomnia (HP:0100785) | 2.24743029 |
| 70 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.22808878 |
| 71 | Neurofibrillary tangles (HP:0002185) | 2.20793994 |
| 72 | Depression (HP:0000716) | 2.20285348 |
| 73 | Absence seizures (HP:0002121) | 2.19917058 |
| 74 | Truncal ataxia (HP:0002078) | 2.19906864 |
| 75 | Inappropriate behavior (HP:0000719) | 2.18423091 |
| 76 | Progressive visual loss (HP:0000529) | 2.17867275 |
| 77 | Drooling (HP:0002307) | 2.17478374 |
| 78 | Excessive salivation (HP:0003781) | 2.17478374 |
| 79 | Systemic lupus erythematosus (HP:0002725) | 2.14100806 |
| 80 | Ankle clonus (HP:0011448) | 2.13026416 |
| 81 | Interstitial pulmonary disease (HP:0006530) | 2.12409949 |
| 82 | Recurrent sinusitis (HP:0011108) | 2.10863306 |
| 83 | Increased cerebral lipofuscin (HP:0011813) | 2.10378445 |
| 84 | Cerebral inclusion bodies (HP:0100314) | 2.09157455 |
| 85 | Papilloma (HP:0012740) | 2.08529909 |
| 86 | Verrucae (HP:0200043) | 2.08529909 |
| 87 | Dilatation of the ascending aorta (HP:0005111) | 2.07264614 |
| 88 | Fragile skin (HP:0001030) | 2.06830526 |
| 89 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.05982446 |
| 90 | Osteolytic defects of the hand bones (HP:0009699) | 2.05982446 |
| 91 | Vascular tortuosity (HP:0004948) | 2.05873474 |
| 92 | Viral hepatitis (HP:0006562) | 2.05033721 |
| 93 | Premature loss of primary teeth (HP:0006323) | 2.04981223 |
| 94 | Hyperparathyroidism (HP:0000843) | 2.04090799 |
| 95 | Atonic seizures (HP:0010819) | 2.03351835 |
| 96 | Pulmonary infiltrates (HP:0002113) | 2.02826439 |
| 97 | Broad-based gait (HP:0002136) | 2.02261698 |
| 98 | Arterial tortuosity (HP:0005116) | 2.01505032 |
| 99 | Distal lower limb amyotrophy (HP:0008944) | 2.00991308 |
| 100 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.98997507 |
| 101 | Mucopolysacchariduria (HP:0008155) | 1.98997507 |
| 102 | Syringomyelia (HP:0003396) | 1.98789564 |
| 103 | Spinal cord lesions (HP:0100561) | 1.98789564 |
| 104 | Genetic anticipation (HP:0003743) | 1.98501968 |
| 105 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.97944323 |
| 106 | Gingivitis (HP:0000230) | 1.97527859 |
| 107 | Recurrent lower respiratory tract infections (HP:0002783) | 1.96341131 |
| 108 | Generalized tonic-clonic seizures (HP:0002069) | 1.94006665 |
| 109 | Recurrent fungal infections (HP:0002841) | 1.93911762 |
| 110 | Loss of speech (HP:0002371) | 1.92411327 |
| 111 | Recurrent cutaneous fungal infections (HP:0011370) | 1.92403168 |
| 112 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.92403168 |
| 113 | Action tremor (HP:0002345) | 1.90579603 |
| 114 | Macroorchidism (HP:0000053) | 1.89519874 |
| 115 | Achilles tendon contracture (HP:0001771) | 1.88880387 |
| 116 | Chronic obstructive pulmonary disease (HP:0006510) | 1.88275901 |
| 117 | Obstructive lung disease (HP:0006536) | 1.88275901 |
| 118 | Recurrent pneumonia (HP:0006532) | 1.87994371 |
| 119 | Spondylolisthesis (HP:0003302) | 1.87731150 |
| 120 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.86346952 |
| 121 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.86346952 |
| 122 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.86346952 |
| 123 | Recurrent skin infections (HP:0001581) | 1.85885361 |
| 124 | Gait imbalance (HP:0002141) | 1.85303574 |
| 125 | Hypoventilation (HP:0002791) | 1.83707133 |
| 126 | Dialeptic seizures (HP:0011146) | 1.82305905 |
| 127 | Increased IgE level (HP:0003212) | 1.82128642 |
| 128 | Amblyopia (HP:0000646) | 1.81832769 |
| 129 | Wide nasal bridge (HP:0000431) | 1.80074123 |
| 130 | Dysdiadochokinesis (HP:0002075) | 1.79782894 |
| 131 | Orchitis (HP:0100796) | 1.79340507 |
| 132 | Apathy (HP:0000741) | 1.78829151 |
| 133 | Chronic diarrhea (HP:0002028) | 1.77408308 |
| 134 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.77288182 |
| 135 | Poor eye contact (HP:0000817) | 1.76257963 |
| 136 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.75314644 |
| 137 | Hypoplasia of the brainstem (HP:0002365) | 1.75314644 |
| 138 | Subacute progressive viral hepatitis (HP:0006572) | 1.75153973 |
| 139 | Bone pain (HP:0002653) | 1.75139171 |
| 140 | Abnormality of the nasal mucosa (HP:0000433) | 1.75117291 |
| 141 | Agitation (HP:0000713) | 1.74253528 |
| 142 | Upper motor neuron abnormality (HP:0002127) | 1.73916344 |
| 143 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.73609577 |
| 144 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.72556296 |
| 145 | Increased variability in muscle fiber diameter (HP:0003557) | 1.72123085 |
| 146 | Thin bony cortex (HP:0002753) | 1.71775172 |
| 147 | Nuclear cataract (HP:0100018) | 1.70841485 |
| 148 | Hypertensive crisis (HP:0100735) | 1.70758827 |
| 149 | Abnormal social behavior (HP:0012433) | 1.70018508 |
| 150 | Impaired social interactions (HP:0000735) | 1.70018508 |
| 151 | Hyperacusis (HP:0010780) | 1.68017203 |
| 152 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.67399779 |
| 153 | Cerebral aneurysm (HP:0004944) | 1.66684552 |
| 154 | Myositis (HP:0100614) | 1.65817821 |
| 155 | Amyotrophic lateral sclerosis (HP:0007354) | 1.65757024 |
| 156 | Malnutrition (HP:0004395) | 1.65395041 |
| 157 | Broad face (HP:0000283) | 1.64706447 |
| 158 | Persistence of primary teeth (HP:0006335) | 1.64007500 |
| 159 | Diminished motivation (HP:0000745) | 1.63625202 |
| 160 | Abnormality of the lower motor neuron (HP:0002366) | 1.63612273 |
| 161 | Distal lower limb muscle weakness (HP:0009053) | 1.63594512 |
| 162 | Retinal atrophy (HP:0001105) | 1.63469269 |
| 163 | Aneurysm (HP:0002617) | 1.62323677 |
| 164 | Megalencephaly (HP:0001355) | 1.62155081 |
| 165 | Urinary urgency (HP:0000012) | 1.62080372 |
| 166 | Myocardial infarction (HP:0001658) | 1.61691600 |
| 167 | Abnormality of the Achilles tendon (HP:0005109) | 1.61562092 |
| 168 | Slow saccadic eye movements (HP:0000514) | 1.60610683 |
| 169 | Skin ulcer (HP:0200042) | 1.59995283 |
| 170 | Genu recurvatum (HP:0002816) | 1.59852880 |
| 171 | Pointed chin (HP:0000307) | 1.57543880 |
| 172 | Absent speech (HP:0001344) | 1.57297821 |
| 173 | Stereotypic behavior (HP:0000733) | 1.56100960 |
| 174 | Limb dystonia (HP:0002451) | 1.55645859 |
| 175 | Lissencephaly (HP:0001339) | 1.52341136 |
| 176 | Protruding tongue (HP:0010808) | 1.52190877 |
| 177 | Elfin facies (HP:0004428) | 1.51267108 |
| 178 | Insidious onset (HP:0003587) | 1.50730496 |
| 179 | Termporal pattern (HP:0011008) | 1.50730496 |
| 180 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.49862120 |
| 181 | Exotropia (HP:0000577) | 1.48745086 |
| 182 | Intellectual disability, profound (HP:0002187) | 1.47965557 |
| 183 | Horizontal nystagmus (HP:0000666) | 1.47277616 |
| 184 | Anxiety (HP:0000739) | 1.46779639 |
| 185 | Aqueductal stenosis (HP:0002410) | 1.46622941 |
| 186 | Open mouth (HP:0000194) | 1.43577092 |
| 187 | Hemiparesis (HP:0001269) | 1.43053962 |
| 188 | Abnormality of binocular vision (HP:0011514) | 1.42231431 |
| 189 | Diplopia (HP:0000651) | 1.42231431 |
| 190 | Progressive inability to walk (HP:0002505) | 1.42217343 |
| 191 | Congenital primary aphakia (HP:0007707) | 1.41269081 |
| 192 | Torticollis (HP:0000473) | 1.41031447 |
| 193 | Heterotopia (HP:0002282) | 1.40902095 |
| 194 | Aortic aneurysm (HP:0004942) | 1.40756396 |
| 195 | Lower limb amyotrophy (HP:0007210) | 1.40284940 |
| 196 | Hyperventilation (HP:0002883) | 1.38468289 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MARK1 | 5.05621166 |
| 2 | TAOK2 | 4.19754144 |
| 3 | IRAK3 | 3.35523694 |
| 4 | MAP3K9 | 3.32784088 |
| 5 | ERN1 | 3.20185481 |
| 6 | NTRK3 | 2.90475142 |
| 7 | MAP3K4 | 2.86968558 |
| 8 | MAP4K1 | 2.70897963 |
| 9 | MINK1 | 2.58610646 |
| 10 | SIK2 | 2.42822076 |
| 11 | DAPK2 | 2.25329344 |
| 12 | PAK6 | 2.24984630 |
| 13 | SMG1 | 2.23382726 |
| 14 | IRAK4 | 2.20119735 |
| 15 | EPHA4 | 2.14054942 |
| 16 | KSR1 | 2.09269173 |
| 17 | MAP3K14 | 2.07302662 |
| 18 | TYK2 | 2.05909494 |
| 19 | ERBB3 | 2.05904002 |
| 20 | MAP2K7 | 2.03369899 |
| 21 | NTRK2 | 1.99632349 |
| 22 | BLK | 1.88875476 |
| 23 | CAMKK1 | 1.80853646 |
| 24 | FGFR4 | 1.79713505 |
| 25 | GRK1 | 1.77819895 |
| 26 | EPHB1 | 1.65304459 |
| 27 | NME2 | 1.62520455 |
| 28 | MAPK13 | 1.61652597 |
| 29 | TBK1 | 1.56155721 |
| 30 | KSR2 | 1.54245653 |
| 31 | MAP3K12 | 1.52794212 |
| 32 | CDK5 | 1.51916468 |
| 33 | TTN | 1.50790293 |
| 34 | JAK1 | 1.48166465 |
| 35 | SCYL2 | 1.47695956 |
| 36 | MAP2K4 | 1.46171419 |
| 37 | SIK1 | 1.45175977 |
| 38 | TESK1 | 1.40612672 |
| 39 | PLK2 | 1.40449839 |
| 40 | CASK | 1.39046682 |
| 41 | RET | 1.37652303 |
| 42 | RIPK4 | 1.29244997 |
| 43 | CAMK1G | 1.29141151 |
| 44 | RIPK1 | 1.29022846 |
| 45 | MAP2K6 | 1.25560091 |
| 46 | NEK9 | 1.25232316 |
| 47 | PAK3 | 1.21045161 |
| 48 | MAP3K8 | 1.19560429 |
| 49 | PHKG2 | 1.19332378 |
| 50 | PHKG1 | 1.19332378 |
| 51 | NTRK1 | 1.17152356 |
| 52 | CSK | 1.13306061 |
| 53 | DAPK1 | 1.12924027 |
| 54 | ERBB4 | 1.12472151 |
| 55 | CSF1R | 1.12351140 |
| 56 | JAK3 | 1.11387635 |
| 57 | IKBKE | 1.10757846 |
| 58 | IRAK2 | 1.09705032 |
| 59 | MAPK11 | 1.08795712 |
| 60 | PAK4 | 1.05549351 |
| 61 | PRKD3 | 1.03595134 |
| 62 | CDK12 | 1.03541825 |
| 63 | MST1R | 1.02123693 |
| 64 | DDR2 | 1.01952687 |
| 65 | DYRK1A | 0.99702354 |
| 66 | MAP3K10 | 0.96015203 |
| 67 | ERBB2 | 0.95434154 |
| 68 | GRK5 | 0.94778567 |
| 69 | EPHB2 | 0.94739821 |
| 70 | MAP3K5 | 0.93915545 |
| 71 | ARAF | 0.93502689 |
| 72 | PRKCH | 0.92769338 |
| 73 | UHMK1 | 0.92601894 |
| 74 | SGK223 | 0.92224665 |
| 75 | SGK494 | 0.92224665 |
| 76 | MAP3K1 | 0.92132017 |
| 77 | TYRO3 | 0.91922922 |
| 78 | MAP3K2 | 0.89909432 |
| 79 | SIK3 | 0.89785128 |
| 80 | PRKD2 | 0.86896309 |
| 81 | STK38 | 0.86060697 |
| 82 | BTK | 0.85607705 |
| 83 | FGR | 0.85263607 |
| 84 | SYK | 0.84928587 |
| 85 | TRIB3 | 0.84899796 |
| 86 | DYRK2 | 0.84004893 |
| 87 | BMPR2 | 0.83986411 |
| 88 | MAP3K3 | 0.83205388 |
| 89 | EEF2K | 0.81249507 |
| 90 | ZAP70 | 0.81112766 |
| 91 | IRAK1 | 0.80147360 |
| 92 | RPS6KA2 | 0.79978814 |
| 93 | STK10 | 0.77945079 |
| 94 | CAMK1D | 0.76858649 |
| 95 | PKN2 | 0.76841877 |
| 96 | CSNK1G2 | 0.76814733 |
| 97 | TAOK1 | 0.76807332 |
| 98 | HCK | 0.76746867 |
| 99 | PDGFRA | 0.76329726 |
| 100 | CDK18 | 0.76159960 |
| 101 | PRKCZ | 0.75876416 |
| 102 | CDK14 | 0.75111719 |
| 103 | FER | 0.75068858 |
| 104 | MOS | 0.74462766 |
| 105 | SGK1 | 0.74016368 |
| 106 | SGK3 | 0.73672689 |
| 107 | MAP2K3 | 0.72858318 |
| 108 | PTK2 | 0.72503647 |
| 109 | LATS2 | 0.72472211 |
| 110 | STK11 | 0.71191927 |
| 111 | CDK15 | 0.71041964 |
| 112 | FRK | 0.69794480 |
| 113 | PRKCG | 0.68415851 |
| 114 | YES1 | 0.67761681 |
| 115 | MAP3K11 | 0.67262961 |
| 116 | ADRBK1 | 0.67149331 |
| 117 | SGK2 | 0.66496356 |
| 118 | ICK | 0.65401384 |
| 119 | CAMKK2 | 0.65284169 |
| 120 | MAPK7 | 0.65185504 |
| 121 | CDC42BPA | 0.63318816 |
| 122 | MAPK12 | 0.63190484 |
| 123 | EPHA3 | 0.62583606 |
| 124 | CAMK2A | 0.62313545 |
| 125 | JAK2 | 0.61986654 |
| 126 | CDK4 | 0.61747555 |
| 127 | PDPK1 | 0.61729939 |
| 128 | MELK | 0.60369297 |
| 129 | FYN | 0.59216957 |
| 130 | TESK2 | 0.57991095 |
| 131 | CDK11A | 0.57601647 |
| 132 | STK24 | 0.57554586 |
| 133 | CCNB1 | 0.57309368 |
| 134 | ROCK2 | 0.56563446 |
| 135 | LYN | 0.56291578 |
| 136 | TGFBR2 | 0.53576796 |
| 137 | IKBKB | 0.52795692 |
| 138 | DYRK1B | 0.52560382 |
| 139 | PDK1 | 0.51490984 |
| 140 | MAP3K13 | 0.50280581 |
| 141 | CDK6 | 0.49184487 |
| 142 | LIMK1 | 0.49071378 |
| 143 | HIPK2 | 0.47909474 |
| 144 | FGFR2 | 0.47728772 |
| 145 | ALK | 0.47095791 |
| 146 | LMTK2 | 0.47088025 |
| 147 | MAP2K1 | 0.46639381 |
| 148 | PTK6 | 0.45535873 |
| 149 | RPS6KA3 | 0.45400739 |
| 150 | DMPK | 0.45348970 |
| 151 | PRKG2 | 0.45183742 |
| 152 | PRKCB | 0.44294899 |
| 153 | ROCK1 | 0.43586019 |
| 154 | PTK2B | 0.42561054 |
| 155 | TNIK | 0.42177305 |
| 156 | BCR | 0.42156557 |
| 157 | PRPF4B | 0.41962483 |
| 158 | LRRK2 | 0.41903301 |
| 159 | MARK2 | 0.41875320 |
| 160 | MAPK9 | 0.41217029 |
| 161 | FGFR1 | 0.41059937 |
| 162 | FES | 0.40434458 |
| 163 | PRKCE | 0.40310639 |
| 164 | FGFR3 | 0.38464952 |
| 165 | PRKAA1 | 0.38060225 |
| 166 | LCK | 0.37846611 |
| 167 | MTOR | 0.35978508 |
| 168 | EPHA2 | 0.34633520 |
| 169 | MAPK4 | 0.33404930 |
| 170 | TRPM7 | 0.32410446 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phototransduction_Homo sapiens_hsa04744 | 6.07593124 |
| 2 | Olfactory transduction_Homo sapiens_hsa04740 | 2.72964481 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.65946967 |
| 4 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.44321503 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 2.40050213 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 2.15685540 |
| 7 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.14237267 |
| 8 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.11338746 |
| 9 | Nicotine addiction_Homo sapiens_hsa05033 | 2.06882327 |
| 10 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.04603801 |
| 11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.01854560 |
| 12 | GABAergic synapse_Homo sapiens_hsa04727 | 1.98317233 |
| 13 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.94760615 |
| 14 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.92994755 |
| 15 | Circadian entrainment_Homo sapiens_hsa04713 | 1.92681438 |
| 16 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.86839437 |
| 17 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.84911508 |
| 18 | Morphine addiction_Homo sapiens_hsa05032 | 1.80711385 |
| 19 | Asthma_Homo sapiens_hsa05310 | 1.77498439 |
| 20 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.74462042 |
| 21 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.72206986 |
| 22 | Other glycan degradation_Homo sapiens_hsa00511 | 1.71049009 |
| 23 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.69984474 |
| 24 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.69120181 |
| 25 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.66039840 |
| 26 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.64982305 |
| 27 | Long-term potentiation_Homo sapiens_hsa04720 | 1.60056521 |
| 28 | Influenza A_Homo sapiens_hsa05164 | 1.58353565 |
| 29 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.57778257 |
| 30 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.57100596 |
| 31 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.55829062 |
| 32 | Tuberculosis_Homo sapiens_hsa05152 | 1.52631826 |
| 33 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.42621163 |
| 34 | Salivary secretion_Homo sapiens_hsa04970 | 1.42315251 |
| 35 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.41248306 |
| 36 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.39472635 |
| 37 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.35870097 |
| 38 | Insulin secretion_Homo sapiens_hsa04911 | 1.34730114 |
| 39 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.33828859 |
| 40 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.33785300 |
| 41 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.32240660 |
| 42 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.32143376 |
| 43 | Hepatitis B_Homo sapiens_hsa05161 | 1.30182948 |
| 44 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.29763784 |
| 45 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.28947876 |
| 46 | Phagosome_Homo sapiens_hsa04145 | 1.28464952 |
| 47 | Measles_Homo sapiens_hsa05162 | 1.27652517 |
| 48 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.26472969 |
| 49 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.25520545 |
| 50 | Renin secretion_Homo sapiens_hsa04924 | 1.24101088 |
| 51 | Glioma_Homo sapiens_hsa05214 | 1.23169080 |
| 52 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.23162317 |
| 53 | Bladder cancer_Homo sapiens_hsa05219 | 1.22481580 |
| 54 | Axon guidance_Homo sapiens_hsa04360 | 1.20916407 |
| 55 | Shigellosis_Homo sapiens_hsa05131 | 1.20224584 |
| 56 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.19370493 |
| 57 | Gap junction_Homo sapiens_hsa04540 | 1.18948094 |
| 58 | Hepatitis C_Homo sapiens_hsa05160 | 1.17477971 |
| 59 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.15098082 |
| 60 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.14569542 |
| 61 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.14236216 |
| 62 | Apoptosis_Homo sapiens_hsa04210 | 1.13246216 |
| 63 | Lysosome_Homo sapiens_hsa04142 | 1.12856137 |
| 64 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.11276862 |
| 65 | Cocaine addiction_Homo sapiens_hsa05030 | 1.05043738 |
| 66 | Endometrial cancer_Homo sapiens_hsa05213 | 1.02902598 |
| 67 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.00865518 |
| 68 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.99751101 |
| 69 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.99087910 |
| 70 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.98200751 |
| 71 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.97848122 |
| 72 | Long-term depression_Homo sapiens_hsa04730 | 0.95467362 |
| 73 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.94522846 |
| 74 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.94509920 |
| 75 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.93999484 |
| 76 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.93614080 |
| 77 | Pertussis_Homo sapiens_hsa05133 | 0.92879544 |
| 78 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.91500200 |
| 79 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.91428574 |
| 80 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.91300761 |
| 81 | Taste transduction_Homo sapiens_hsa04742 | 0.90035104 |
| 82 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.89815388 |
| 83 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.89787495 |
| 84 | Prion diseases_Homo sapiens_hsa05020 | 0.89449596 |
| 85 | Colorectal cancer_Homo sapiens_hsa05210 | 0.88596337 |
| 86 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.87872504 |
| 87 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.87037900 |
| 88 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.86739588 |
| 89 | Alcoholism_Homo sapiens_hsa05034 | 0.86406257 |
| 90 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.85848041 |
| 91 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.85685275 |
| 92 | Melanogenesis_Homo sapiens_hsa04916 | 0.85054939 |
| 93 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.84958285 |
| 94 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.84380497 |
| 95 | Malaria_Homo sapiens_hsa05144 | 0.81878169 |
| 96 | HTLV-I infection_Homo sapiens_hsa05166 | 0.79942120 |
| 97 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.79626209 |
| 98 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.78698111 |
| 99 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.77573520 |
| 100 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.77555122 |
| 101 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.77096471 |
| 102 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.76701946 |
| 103 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.76486006 |
| 104 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.75105023 |
| 105 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.73810375 |
| 106 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.71977556 |
| 107 | Prostate cancer_Homo sapiens_hsa05215 | 0.71699744 |
| 108 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.71699073 |
| 109 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.70631285 |
| 110 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.70575436 |
| 111 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.70374071 |
| 112 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.68378675 |
| 113 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.66441614 |
| 114 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.65952313 |
| 115 | Galactose metabolism_Homo sapiens_hsa00052 | 0.64957689 |
| 116 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.64863762 |
| 117 | Amoebiasis_Homo sapiens_hsa05146 | 0.64842094 |
| 118 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.64611924 |
| 119 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.64197130 |
| 120 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.64185410 |
| 121 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.63666393 |
| 122 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.63477831 |
| 123 | Circadian rhythm_Homo sapiens_hsa04710 | 0.63326482 |
| 124 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.62917782 |
| 125 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.62645055 |
| 126 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.62308433 |
| 127 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.62278941 |
| 128 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.62180568 |
| 129 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.62179802 |
| 130 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.62158022 |
| 131 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.62126675 |
| 132 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.61325320 |
| 133 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.60501586 |
| 134 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.60222536 |
| 135 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.60089898 |
| 136 | Endocytosis_Homo sapiens_hsa04144 | 0.60089529 |
| 137 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.59984298 |
| 138 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.59494064 |
| 139 | Legionellosis_Homo sapiens_hsa05134 | 0.59170466 |
| 140 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.58836026 |
| 141 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.57996275 |
| 142 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.56765034 |
| 143 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.56339690 |
| 144 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.55943660 |
| 145 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.54983022 |
| 146 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.54665230 |
| 147 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.53603877 |
| 148 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.52960386 |
| 149 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.52951213 |
| 150 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.52443951 |
| 151 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.52352260 |
| 152 | Focal adhesion_Homo sapiens_hsa04510 | 0.52251759 |
| 153 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.50119331 |
| 154 | Platelet activation_Homo sapiens_hsa04611 | 0.49430716 |
| 155 | Thyroid cancer_Homo sapiens_hsa05216 | 0.47942816 |
| 156 | Salmonella infection_Homo sapiens_hsa05132 | 0.47724512 |
| 157 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.47685456 |
| 158 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.46033195 |
| 159 | Melanoma_Homo sapiens_hsa05218 | 0.45355519 |
| 160 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.44941968 |
| 161 | Viral myocarditis_Homo sapiens_hsa05416 | 0.43393852 |
| 162 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.42742868 |

